2025
SJR Q2
JCR Q2 · 2,8
154 eşleşen makale
SCIE
Dergi ayrıntısı
Strahlentherapie und Onkologie
- Yayıncı
- Springer Science and Business Media Deutschland GmbH
- Ülke
- Germany · Western Europe
- Tür
- journal
- ISSN
-
017971581439099X
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,769
- Quartile Q2
- H-Index 83
- Atıf/yayın 2,11
- Doküman (3y) 423
- Atıf (3y) 868
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,8
- 5Y JIF 2,7
- JCI 0,65
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
Alanlar
WoS kategorileri
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,769 | 2,8 | 2,7 | 0,65 | Q2 | 83 |
| 2024 | Q2 | Q2 | 0,692 | 2,5 | 2,6 | 0,65 | Q2 | 81 |
| 2023 | Q1 | Q2 | 0,907 | 2,7 | 2,8 | 0,73 | Q2 | 81 |
| 2022 | Q1 | Q2 | 0,885 | 3,1 | 2,7 | 0,7 | Q2 | 81 |
| 2021 | Q1 | Q2 | 0,915 | 4 | 3,2 | 0,79 | Q2 | 81 |
| 2020 | Q2 | Q2 | 0,801 | 3,6 | 3 | 0,81 | Q2 | 81 |
| 2019 | Q1 | Q2 | 0,909 | 2,9 | 2,5 | 0,79 | Q2 | 81 |
| 2018 | — | Q2 | — | 2,7 | 2,5 | 0,79 | Q2 | — |
| 2017 | Q1 | Q2 | 1,116 | 2,5 | 2,2 | 0,81 | Q2 | 81 |
| 2016 | Q1 | Q2 | 0,981 | 2,7 | 2,2 | — | — | 81 |
| 2015 | Q1 | Q1 | 1,103 | 2,9 | 2,4 | — | — | 81 |
| 2014 | Q1 | Q1 | 1,144 | 2,9 | 2,4 | — | — | 81 |
| 2013 | Q1 | Q2 | 1,106 | 2,7 | 2,3 | — | — | 81 |
| 2012 | Q1 | Q1 | 1,276 | 4,2 | 2,8 | — | — | 81 |
| 2011 | Q1 | Q1 | 1,335 | 3,6 | 2,5 | — | — | 81 |
| 2010 | Q1 | Q1 | 1,103 | 3,6 | 2,5 | — | — | 81 |
| 2009 | — | Q1 | — | 3,8 | 2,7 | — | — | — |
| 2008 | — | Q1 | — | 3 | 2,3 | — | — | — |
| 2007 | — | Q1 | — | 3,4 | 2,5 | — | — | — |
| 2006 | — | Q1 | — | 3,7 | — | — | — | — |
| 2005 | — | Q1 | — | 3,5 | — | — | — | — |
| 2004 | — | Q1 | — | 3,1 | — | — | — | — |
| 2003 | — | Q1 | — | 2,6 | — | — | — | — |
| 2002 | — | Q1 | — | 2,8 | — | — | — | — |
| 2001 | — | Q1 | — | 3 | — | — | — | — |
| 2000 | — | Q1 | — | 2,8 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q3 | Q2 | 179/333 |
| 2025 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 80/217 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q2 | 188/328 |
| 2024 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 82/213 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q2 | 163/322 |
| 2023 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 68/204 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q2 | 149/241 |
| 2022 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 54/135 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q2 | 134/245 |
| 2021 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 52/136 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q2 | 146/242 |
| 2020 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 44/133 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q2 | 142/244 |
| 2019 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 44/134 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q2 | 137/230 |
| 2018 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 49/129 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q2 | 151/223 |
| 2017 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 47/129 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 123/217 |
| 2016 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 35/127 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 108/213 |
| 2015 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 29/124 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 102/211 |
| 2014 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 28/125 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 101/203 |
| 2013 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 33/122 |
| 2012 | ONCOLOGY | SCIE | Q2 | — | 50/197 |
| 2012 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 12/120 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 58/196 |
| 2011 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 18/116 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 60/185 |
| 2010 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 19/113 |
| 2009 | ONCOLOGY | SCIE | Q2 | — | 50/166 |
| 2009 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 12/104 |
| 2008 | ONCOLOGY | SCIE | Q2 | — | 60/143 |
| 2008 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 23/92 |
| 2007 | ONCOLOGY | SCIE | Q2 | — | 50/132 |
| 2007 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 13/87 |
| 2006 | ONCOLOGY | SCIE | Q2 | — | 44/127 |
| 2006 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 11/85 |
| 2005 | ONCOLOGY | SCIE | Q2 | — | 42/123 |
| 2005 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 11/84 |
| 2004 | ONCOLOGY | SCIE | Q2 | — | 43/123 |
| 2004 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 14/84 |
| 2003 | ONCOLOGY | SCIE | Q2 | — | 47/120 |
| 2003 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 16/83 |
| 2002 | ONCOLOGY | SCIE | Q2 | — | 35/114 |
| 2002 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 9/81 |
| 2001 | ONCOLOGY | SCIE | Q2 | — | 29/107 |
| 2001 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 9/81 |
| 2000 | ONCOLOGY | SCIE | Q2 | — | 26/103 |
| 2000 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 8/80 |